维普中文期刊产品整合服务
6篇 您的检索式:作者名="E.Foley"
    题名 作者 年代 出处 被引量
1Efficacy and tolerability of vildagliptin in drug‐na?ve patients with type 2 diabetes and mild hyperglycaemia*显示文摘W. A.Scherbaum A.Schweizer A.Mari P. M.Nilsson G.Lalanne S.Jauffret J. E.Foley 2008Diabetes Obesity and Metabolism2008,,8:2
2An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials显示文摘M.Ligueros‐Saylan J. E.Foley A.Schweizer A.Couturier W.Kothny 2010Diabetes, Obesity and Metabolism2010,,:1
3Assessing the cardio–cerebrovascular safety of vildagliptin: meta‐analysis of adjudicated events from a large Phase III type 2 diabetes population显示文摘A.Schweizer S.Dejager J. E.Foley A.Couturier M.Ligueros‐Saylan W.Kothny 2010Diabetes Obesity and Metabolism2010,,6:1
4The effect of dipeptidyl peptidase‐4 inhibition on gastric volume, satiation and enteroendocrine secretion in type?2 diabetes: a double‐blind, placebo‐controlled crossover study显示文摘AdrianVella GerliesBock Paula D.Giesler Duane B.Burton Denise B.Serra Monica LiguerosSaylan Carolyn F.Deacon James E.Foley Robert A.Rizza MichaelCamilleri 2008Clinical Endocrinology2008,,5:1
5Vildagliptin add‐on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2‐year study显示文摘D. R.Matthews S.Dejager B.Ahren V.Fonseca E.Ferrannini A.Couturier J. E.Foley B.Zinman 2010Diabetes Obesity and Metabolism2010,,9:1
6Comparison between vildagliptin and metformin to sustain reductions in HbA<sub>1c</sub> over 1?year in drug‐na?ve patients with Type?2 diabetes显示文摘A.Schweizer A.Couturier J. E.Foley S.Dejager 2007Diabetic Medicine2007,,9:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费